Gabriel Leung - Net Worth and Insider Trading
Gabriel Leung Net Worth
The estimated net worth of Gabriel Leung is at least $1 Million dollars as of 2024-03-29. Gabriel Leung is the Director of NovoCure Ltd and owns about 72,859 shares of NovoCure Ltd (NVCR) stock worth over $1 Million. Gabriel Leung is also the Director of Albany Molecular Research Inc and owns about 13,254 shares of Albany Molecular Research Inc (AMRI) stock worth over $288,142. Details can be seen in Gabriel Leung's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gabriel Leung has not made any transactions after 2021-08-05 and currently still holds the listed stock(s).
Transaction Summary of Gabriel Leung
Gabriel Leung Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gabriel Leung owns 4 companies in total, including NovoCure Ltd () , Pernix Therapeutics Holdings Inc () , and Albany Molecular Research Inc () among others .
Click here to see the complete history of Gabriel Leung’s form 4 insider trades.
Insider Ownership Summary of Gabriel Leung
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
NovoCure Ltd | 2021-08-05 | director | |
Pernix Therapeutics Holdings Inc | 2018-05-22 | director | |
Albany Molecular Research Inc | 2015-03-02 | director | |
Delcath Systems Inc | 2011-03-30 | director |
Gabriel Leung Latest Holdings Summary
Gabriel Leung currently owns a total of 2 stocks. Among these stocks, Gabriel Leung owns 72,859 shares of NovoCure Ltd (NVCR) as of August 5, 2021, with a value of $1 Million and a weighting of 79.81%. Gabriel Leung also owns 13,254 shares of Albany Molecular Research Inc (AMRI) as of December 7, 2011, with a value of $288,142 and a weighting of 20.19%.
Latest Holdings of Gabriel Leung
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
NVCR | NovoCure Ltd | 2021-08-05 | 72,859 | 15.63 | 1,138,786 |
AMRI | Albany Molecular Research Inc | 2011-12-07 | 13,254 | 21.74 | 288,142 |
Holding Weightings of Gabriel Leung
Gabriel Leung Form 4 Trading Tracker
According to the SEC Form 4 filings, Gabriel Leung has made a total of 23 transactions in NovoCure Ltd (NVCR) over the past 5 years, including 0 buys and 23 sells. The most-recent trade in NovoCure Ltd is the sale of 1,000 shares on August 5, 2021, which brought Gabriel Leung around $152,500.
According to the SEC Form 4 filings, Gabriel Leung has made a total of 0 transactions in Albany Molecular Research Inc (AMRI) over the past 5 years. The most-recent trade in Albany Molecular Research Inc is the acquisition of 8,000 shares on December 7, 2011, which cost Gabriel Leung around $19,200.
Insider Trading History of Gabriel Leung
- 1
Gabriel Leung Trading Performance
GuruFocus tracks the stock performance after each of Gabriel Leung's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gabriel Leung is 15.25%. GuruFocus also compares Gabriel Leung's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gabriel Leung within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gabriel Leung's insider trading performs compared to the benchmark.
Performance of Gabriel Leung
Average Relative Return
119.86%
Outperforming Transactions
100%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Relative Return(%) | 22.03 | 15.25 | 5.51 | 119.86 | 111.33 | 90.2 |
Relative Return to S&P 500(%) | 20.7 | 7.98 | 1.23 | 107.44 | 91.69 | 72.12 |
Gabriel Leung Ownership Network
Ownership Network List of Gabriel Leung
Ownership Network Relation of Gabriel Leung
Gabriel Leung Owned Company Details
What does NovoCure Ltd do?
Who are the key executives at NovoCure Ltd?
Gabriel Leung is the director of NovoCure Ltd. Other key executives at NovoCure Ltd include Chief Financial Officer Wilhelmus Cm Groenhuysen , President & CNS Cancers US Frank X Leonard , and Chief Commercial Officer Pritesh Shah .
NovoCure Ltd () Insider Trades Summary
Over the past 18 months, Gabriel Leung made no insider transaction in NovoCure Ltd (). Other recent insider transactions involving NovoCure Ltd () include a net sale of 75,808 shares made by Frank X Leonard , a net sale of 25,323 shares made by Pritesh Shah , and a net sale of 32,769 shares made by Wilhelmus Cm Groenhuysen .
In summary, during the past 3 months, insiders sold 10,224 shares of NovoCure Ltd () in total and bought 0 shares, with a net sale of 10,224 shares. During the past 18 months, 366,202 shares of NovoCure Ltd () were sold and 0 shares were bought by its insiders, resulting in a net sale of 366,202 shares.
NovoCure Ltd ()'s detailed insider trading history can be found in Insider Trading Tracker table.
NovoCure Ltd Insider Transactions
Gabriel Leung Mailing Address
Above is the net worth, insider trading, and ownership report for Gabriel Leung. You might contact Gabriel Leung via mailing address: C/o Pernix Therapeutics Holdings, Inc., 10 North Park Place, Suite 201, Morristown Nj 07960.